MOG Antibody-Induced CNS Demyelination: from Specificity to Function

A11

IgG antibodies (Abs) specific for central nervous system (CNS) antigens such as myelin oligoden-drocytes glycoprotein (MOG) are considered crucial effector molecules in some patients with mul-tiple sclerosis (MS) and related diseases. In the proposed project, we will characterize structural requirements for immune recognition of human MOG and determine IgG-Fc biophysical profiles and effector functions linked to in vivo pathogenicity of human MOG-Abs. In detail, these are our reseach questions:

    1. Do patients with circulating MOG-specific B cells particularly benefit from B cell depletion therapy?
    2. What are the structural requirements for immune recognition of human MOG?
    3. What are the Fc biophysical profiles and effector functions of human MOG-Abs?
    4. How do human MOG-Abs act pathogenetic in vivo?


Meyer et al. J. Immunol. 2013
Principal Investigators:

Prof. Dr. med. Edgard Meinl
Institut für Klinische Neuroimmunologie
LMU München
edgar.meinl@med.uni-muenchen.de

Univ.-Prof. Dr. med. Jan Lünemann
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster
jan.luenemann@ukmuenster.de

News

Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more